CIPLA TADALAFIL 20 tadalafil 20 mg film-coated tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

tadalafil, Quantity: 20 mg

MAH:

Cipla Australia Pty Ltd

INN:

Tadalafil

pharmaceutical_form:

Tablet

composition:

Excipient Ingredients: microcrystalline cellulose; sodium lauryl sulfate; hyprolose; croscarmellose sodium; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow

administration_route:

Oral

units_in_package:

8, 2, 4, 1

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

CIPLA TADALAFIL is indicated for the treatment of: ? erectile dysfunction (ED) in adult males ? moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males

leaflet_short:

Visual Identification: Yellow coloured, capsule shaped, biconvex film coated tablet with "T 20" debossed on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2017-03-27